Skip to content

CEL SCI CORP

CVM

CIK 0000725363 · Biological Products, (No Diagnostic Substances) · NYSE

← back to feed
Revenue (TTM)
$67.82K
+326.2% YoY Q2 May 2026
Net Income (TTM)
−$23.17M
+5.6% YoY Q2 May 2026
EPS Diluted (TTM)
−$5.04
+59.0% YoY Q2 May 2026
Gross Margin
—
Q2 May 2026
Operating Margin
-33,291.8%
Q2 May 2026
Net Margin
-34,168.3%
Q2 May 2026
Free Cash Flow (TTM)
−$17.85M
Q2 May 2026
Cash
$5.14M
Q2 May 2026
Total Debt
—
Q2 May 2026
Shares Outstanding
8.49M sh
Q2 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings